Cardiovascular Drug Discoveries 2008: What's in the Pipeline - 0 views
-
avivajazz jazzaviva on 15 Oct 09Generx (alferminogene tadenovec, Ad5FGF-4) from Cardium Therapeutics, which is in Phase III for myocardial ischaemia & angina. Darapladib from GSK inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).